Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
13.79
-0.28 (-1.96%)
At close: Oct 16, 2025, 3:59 PM
13.50
-2.10%
After-hours: Oct 16, 2025, 07:29 PM EDT
-1.96% (1D)
| Bid | 13.45 |
| Market Cap | 28.23M |
| Revenue (ttm) | 2.13K |
| Net Income (ttm) | -10.44M |
| EPS (ttm) | -8.88 |
| PE Ratio (ttm) | -1.55 |
| Forward PE | -2.6 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 13.82 |
| Volume | 15,669 |
| Avg. Volume (20D) | 28,578 |
| Open | 13.98 |
| Previous Close | 14.06 |
| Day's Range | 13.51 - 14.12 |
| 52-Week Range | 8.74 - 22.90 |
| Beta | 0.99 |
| Ex-Dividend Date | n/a |
About CVKD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CVKD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CVKD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+23.72%
Cadrenal Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdatePONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #AFib--Cadrenal Therapeutics reports on Second Quarter 2025 financial results and provides corporate update on strategic clinical trial plans.
